Interní Med. 2010; 12(1): 18-21

Drug therapy in patients with impaired renal function

MUDr.Jan Vachek, prof.MUDr.Vladimír Tesař, DrSc.
Klinika nefrologie VFN, Praha

Patients with chronic kidney disease (CKD) are more threatened by drug adverse effects and interactions. Pathophysiological changes

caused by CKD influence many pharmacokinetics properties, resulting in diminished glomerural filtration rate (GF) and altered tubular

secretion and reabsorbtion. Before setting a patient on a new drug, next scheme is recommended: estimating renal functions (preferably

creatinine clearance), evaluation of drug clearance and estimating initial and maintenance dose, checking of plasma level, and

dose revision, if appropriate. In renal-excreted drugs, dosing scheme may be adjusted by dose reducing, interval prolongation or both.

Choosing a suitable drug in dialysed patients is a common problem. It is neccessary to consider binding to plasma albumin, molecular

weight as well as many further aspects, e.g. determined by anuria and consequent need of water restriction. Selection of a suitable drug

and adequate dosing is essential for preventing adverse effects and obtaining optimal therapeutic effect.

Keywords: drug therapy, pharmacokinetics, renal function, chronic kidney disease, hemodialysis, glomerular filtration rate

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vachek J, Tesař V. Drug therapy in patients with impaired renal function. Interní Med. 2010;12(1):18-21.
Download citation

References

  1. Schmid P, Fischer A, Wuillemin W. Prevalence of impaired renal function and use of anticoagulants in medical inpatients. Paper presented at 50th annual meeting of the Society for Research on Thrombosis and Haemostaseology. Basel, Switzerland; 2006.
  2. Cantu TG, Ellerbeck EF, Yun SW, et al. Drug prescribing for patients with changing renal function. Am J Hosp Pharm. 1992; 49: 2944-2948. Go to original source...
  3. Salomon L, et al. Medication misuse in hospitalized patients with renal impairment. International Journal for Quality in Health Care 2003; 15: 331-335. Go to original source... Go to PubMed...
  4. Lam YW, Banerji S, Hatfield C, et al. Principles of drug administration in renal insufficiency. Clin Pharmacokinet 1997; 32: 30-57. Go to original source... Go to PubMed...
  5. Keller CK, Geberth SK. Praxis der Nephrologie. Heidelberg: Springer 2007. Go to original source...
  6. Bertsche T, Haefeli WE. Individualisierte Arzneimitteltherapie bei Niereninsuffizienz. Pharmazeutische Zeitung Online 2006; 8. Dostupné pod http://www.pharmazeutische-zeitung.de/index.php? id=773 ke dni 21. 10. 2009.
  7. Steddon S, et al (Ed.). Oxford Handbook of Nephrology and Hypertension. Oxford: OUP 2006. Go to original source...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.